Evidence map›Paper›PMID 26933016›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

The Relationship Between Invasive Nontyphoidal Salmonella Disease, Other Bacterial Bloodstream Infections, and Malaria in Sub-Saharan Africa.

Se Eun Park, Gi Deok Pak, Peter Aaby, Yaw Adu-Sarkodie, Mohammad Ali, Abraham Aseffa, Holly M Biggs, Morten Bjerregaard-Andersen, Robert F Breiman, John A Crump and 35 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07416461 (Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-Typhoidal Salmonella Disease), which is not on this map. Cited by 57 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 8 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07416461 recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-Typhoidal Salmonella Disease (VINS)

TypeobservationalSponsorInternational Vaccine InstituteRan2025 to 2027Enrolled10,000ConditionsInvasive Non-Typhoidal Salmonella Disease, Malaria, Malaria VaccineArmsR21/Matrix-M malaria vaccine
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 8 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 20 institutions in 18 countries.

Se Eun ParkInternational Vaccine Institute, Seoul, Republic of Korea.
Gi Deok PakInternational Vaccine Institute, Seoul, Republic of Korea.
Peter AabyBandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark.
Yaw Adu-SarkodieKumasi Centre for Collaborative Research in Tropical Medicine School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Mohammad AliInternational Vaccine Institute, Seoul, Republic of Korea Johns Hopkins University, Baltimore, Maryland.
Abraham AseffaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Holly M BiggsDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Morten Bjerregaard-AndersenBandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark.
Robert F BreimanCenters for Disease Control and Prevention, Nairobi, Kenya Emory Global Health Institute, Emory University, Atlanta, Georgia.
John A CrumpDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina Kilimanjaro Christian Medical Centre, Moshi, Tanzania Duke Global Health Institute, Duke University, Durham, North Carolina Centre for International Health, University of Otago, Dunedin, New Zealand.
Ligia Maria Cruz EspinozaInternational Vaccine Institute, Seoul, Republic of Korea.
Muna Ahmed EltayebUniversity of Gezira, Wad Medani, Sudan.
Nagla GasmelseedUniversity of Gezira, Wad Medani, Sudan.
Julian T HertzDivision of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Justin ImInternational Vaccine Institute, Seoul, Republic of Korea.
Anna JaegerBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Leon Parfait KaboreSchiphra Hospital, Ouagadougou, Burkina Faso.
Vera von KalckreuthInternational Vaccine Institute, Seoul, Republic of Korea.
Karen H KeddyNational Institute for Communicable Diseases Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Frank KoningsInternational Vaccine Institute, Seoul, Republic of Korea.
Ralf KrumkampBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Calman A MacLennanJenner Institute, Nuffield Department of Medicine, University of Oxford Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Christian G MeyerInstitute of Tropical Medicine, Eberhard-Karls University Tübingen, Germany.
Joel M MontgomeryCenters for Disease Control and Prevention, Nairobi, Kenya.
Aissatou Ahmet NiangInstitute Pasteur Senegal, Dakar.
Chelsea NicholsInternational Vaccine Institute, Seoul, Republic of Korea.
Beatrice OlackKenya Medical Research Institute (KEMRI), Nairobi.
Ursula PanznerInternational Vaccine Institute, Seoul, Republic of Korea.
Jin Kyung ParkInternational Vaccine Institute, Seoul, Republic of Korea.
Henintsoa RabezanaharyUniversity of Antananarivo, Madagascar.
Raphaël RakotozandrindrainyUniversity of Antananarivo, Madagascar.
Emmanuel SampoSchiphra Hospital, Ouagadougou, Burkina Faso Institut Supérieur des Sciences de la Population, University of Ouagadougou, Burkina Faso.
Nimako SarpongKumasi Centre for Collaborative Research in Tropical Medicine.
Heidi Schütt-GerowittInternational Vaccine Institute, Seoul, Republic of Korea Institute of Medical Microbiology, University of Cologne, Germany.
Arvinda SookaNational Institute for Communicable Diseases.
Abdramane Bassiahi SouraInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Burkina Faso.
Amy Gassama SowInstitute Pasteur Senegal, Dakar Université Cheikh Anta Diop de Dakar, Senegal.
Adama TallInstitute Pasteur Senegal, Dakar.
Mekonnen TeferiArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Biruk YeshitelaArmauer Hansen Research Institute, Addis Ababa, Ethiopia.
Jürgen MayBernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Thomas F WierzbaInternational Vaccine Institute, Seoul, Republic of Korea.
John D ClemensInternational Vaccine Institute, Seoul, Republic of Korea International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka Fielding School of Public Health, University of California, Los Angeles.
Stephen BakerHospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Florian MarksInternational Vaccine Institute, Seoul, Republic of Korea.
International Vaccine Institute · KRArmauer Hansen Research Institute · ETBernhard Nocht Institute for Tropical Medicine · DEInstitut Pasteur de Dakar · SNBandim Health Project · GWCenters for Disease Control and Prevention · KEDuke Medical Center · USInstitut Superieur Des Sciences De La Population · BFNational Center for Communicable Diseases · MNUniversity of Antananarivo · MGUniversity of Gezira · SDHospital for Tropical Diseases · VNJenner Institute · GBJohns Hopkins University · USKenya Medical Research Institute · KEKilimanjaro Christian Medical Centre · TZKumasi Centre for Collaborative Research in Tropical Medicine · GHKwame Nkrumah University of Science and Technology · GHUniversity of California, Los Angeles · USUniversity of Cologne · DE

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Susanna Naggie, GEORGIA Doris TOMARAS · 2005 to 2026
$50.5M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HAYNES, BARTON F · 2005 to 2005
$14.9M
HIV/AIDS Clinical Trials UnitU01AI069484 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2007 to 2011
$14.6M
International Clinical Trials UnitU01AI062563 · NIAID · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2004 to 2007
$4.0M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Biotechnology and Biological Sciences Research Council BB/J010367FIC NIH HHS R01 TW009237FIC NIH HHS R01TW009237FIC NIH HHS R24 TW007988NIAID NIH HHS P30 AI064518NIAID NIH HHS U01 AI062563NIAID NIH HHS U01 AI067854NIAID NIH HHS U01 AI069484PHS HHS D43 PA-03018Wellcome Trust 100087Wellcome Trust 100087/Z/12/Z
6 · The paper itself

Abstract

backgroundCountry-specific studies in Africa have indicated that Plasmodium falciparum is associated with invasive nontyphoidal Salmonella (iNTS) disease. We conducted a multicenter study in 13 sites in Burkina Faso, Ethiopia, Ghana, Guinea-Bissau, Kenya, Madagascar, Senegal, South Africa, Sudan, and Tanzania to investigate the relationship between the occurrence of iNTS disease, other systemic bacterial infections, and malaria.

methodsFebrile patients received a blood culture and a malaria test. Isolated bacteria underwent antimicrobial susceptibility testing, and the association between iNTS disease and malaria was assessed.

resultsA positive correlation between frequency proportions of malaria and iNTS was observed (P = .01; r = 0.70). Areas with higher burden of malaria exhibited higher odds of iNTS disease compared to other bacterial infections (odds ratio [OR], 4.89; 95% CI, 1.61-14.90; P = .005) than areas with lower malaria burden. Malaria parasite positivity was associated with iNTS disease (OR, 2.44; P = .031) and gram-positive bacteremias, particularly Staphylococcus aureus, exhibited a high proportion of coinfection with Plasmodium malaria. Salmonella Typhimurium and Salmonella Enteritidis were the predominant NTS serovars (53/73; 73%). Both moderate (OR, 6.05; P = .0001) and severe (OR, 14.62; P < .0001) anemia were associated with iNTS disease.

conclusionsA positive correlation between iNTS disease and malaria endemicity, and the association between Plasmodium parasite positivity and iNTS disease across sub-Saharan Africa, indicates the necessity to consider iNTS as a major cause of febrile illness in malaria-holoendemic areas. Prevention of iNTS disease through iNTS vaccines for areas of high malaria endemicity, targeting high-risk groups for Plasmodium parasitic infection, should be considered.

Indexed as

CoinfectionMalariaSalmonella entericaSalmonella InfectionsAdolescentAdultAfrica South of the SaharaAnalysis of VarianceChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleYoung Adultinvasive NTSmalariaNTSPlasmodiumSalmonella

Identifiers

PMID26933016
PMCPMC4772835
OpenAlexW2292215690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.